Table 2.
No Obstructive CAD n=381 |
Obstructive CAD n=4941 |
P-value | |
---|---|---|---|
Baseline | |||
SAQ Angina Frequency | 85.2±21.0 | 87.6±19.7 | 0.031 |
SAQ Disease Perception/Quality of Life | 60.5± 24.1 | 63.8± 23.2 | 0.006 |
SAQ Physical Limitation | 84.4± 24.3 | 86.4± 21.9 | 0.101 |
SAQ Treatment Satisfaction | 92.3± 11.9 | 94.4± 10.3 | <0.001 |
SF-12 Mental Component Score | 47.4± 12.6 | 50.2± 11.3 | <0.001 |
SF-12 Physical Component Score | 42.1± 12.9 | 43.4± 12.1 | 0.065 |
12 Months | |||
SAQ Angina Frequency | 93.3±15.9 | 92.7±16.2 | 0.559 |
SAQ Disease Perception/Quality of Life | 79.6± 22.7 | 83.2± 19.5 | 0.004 |
SAQ Physical Limitation | 91.6± 19.3 | 93.9± 16.0 | 0.066 |
SAQ Treatment Satisfaction | 90.4± 15.4 | 92.9± 13.0 | 0.002 |
SF-12 Mental Component Score | 50.3± 11.5 | 52.8± 9.8 | <0.001 |
SF-12 Physical Component Score | 41.3± 12.0 | 44.5± 11.8 | <0.001 |
SAQ, Seattle Angina Questionnaire; SF-12, Medical Outcomes Study 12-item Short Form
*Scores for the SAQ and SF-12 range from 0-100, with higher scores indicating less disease burden